CAI
Price
$22.00
Change
+$0.75 (+3.53%)
Updated
Feb 6 closing price
Capitalization
6.21B
17 days until earnings call
Intraday BUY SELL Signals
LIXT
Price
$2.95
Change
-$0.07 (-2.32%)
Updated
Feb 6 closing price
Capitalization
25.85M
Intraday BUY SELL Signals
Interact to see
Advertisement

CAI vs LIXT

Header iconCAI vs LIXT Comparison
Open Charts CAI vs LIXTBanner chart's image
Caris Life Sciences
Price$22.00
Change+$0.75 (+3.53%)
Volume$1.68M
Capitalization6.21B
Lixte Biotechnology Holdings
Price$2.95
Change-$0.07 (-2.32%)
Volume$78.78K
Capitalization25.85M
CAI vs LIXT Comparison Chart in %
CAI
Daily Signal:
Gain/Loss:
LIXT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CAI vs. LIXT commentary
Feb 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAI is a Hold and LIXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 08, 2026
Stock price -- (CAI: $22.00 vs. LIXT: $2.95)
Brand notoriety: CAI and LIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAI: 69% vs. LIXT: 86%
Market capitalization -- CAI: $6.21B vs. LIXT: $25.85M
CAI [@Biotechnology] is valued at $6.21B. LIXT’s [@Biotechnology] market capitalization is $25.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAI’s FA Score shows that 0 FA rating(s) are green whileLIXT’s FA Score has 0 green FA rating(s).

  • CAI’s FA Score: 0 green, 5 red.
  • LIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, LIXT is a better buy in the long-term than CAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAI’s TA Score shows that 4 TA indicator(s) are bullish while LIXT’s TA Score has 3 bullish TA indicator(s).

  • CAI’s TA Score: 4 bullish, 6 bearish.
  • LIXT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CAI is a better buy in the short-term than LIXT.

Price Growth

CAI (@Biotechnology) experienced а -5.01% price change this week, while LIXT (@Biotechnology) price change was -20.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

CAI is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($6.21B) has a higher market cap than LIXT($25.8M). CAI YTD gains are higher at: -18.458 vs. LIXT (-24.936). LIXT has higher annual earnings (EBITDA): -4.07M vs. CAI (-100.84M). CAI has more cash in the bank: 755M vs. LIXT (5.34M). LIXT has less debt than CAI: LIXT (100K) vs CAI (427M). CAI has higher revenues than LIXT: CAI (649M) vs LIXT (0).
CAILIXTCAI / LIXT
Capitalization6.21B25.8M24,058%
EBITDA-100.84M-4.07M2,476%
Gain YTD-18.458-24.93674%
P/E RatioN/AN/A-
Revenue649M0-
Total Cash755M5.34M14,133%
Total Debt427M100K427,000%
FUNDAMENTALS RATINGS
CAI vs LIXT: Fundamental Ratings
CAI
LIXT
OUTLOOK RATING
1..100
642
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8765
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAI's Valuation (50) in the Finance Or Rental Or Leasing industry is in the same range as LIXT (52) in the null industry. This means that CAI’s stock grew similarly to LIXT’s over the last 12 months.

CAI's Profit vs Risk Rating (100) in the Finance Or Rental Or Leasing industry is in the same range as LIXT (100) in the null industry. This means that CAI’s stock grew similarly to LIXT’s over the last 12 months.

CAI's SMR Rating (100) in the Finance Or Rental Or Leasing industry is in the same range as LIXT (100) in the null industry. This means that CAI’s stock grew similarly to LIXT’s over the last 12 months.

LIXT's Price Growth Rating (65) in the null industry is in the same range as CAI (87) in the Finance Or Rental Or Leasing industry. This means that LIXT’s stock grew similarly to CAI’s over the last 12 months.

LIXT's P/E Growth Rating (100) in the null industry is in the same range as CAI (100) in the Finance Or Rental Or Leasing industry. This means that LIXT’s stock grew similarly to CAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAILIXT
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
33%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
61%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CAI
Daily Signal:
Gain/Loss:
LIXT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLUX1.190.11
+10.19%
Flux Power Holdings
DAWN11.410.93
+8.87%
Day One Biopharmaceuticals
BCS26.410.93
+3.65%
Barclays PLC
OABI1.700.05
+3.03%
OmniAb
GLBE32.610.50
+1.56%
Global-E Online Ltd

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
+3.53%
BMEA - CAI
35%
Loosely correlated
+7.02%
CRDF - CAI
28%
Poorly correlated
+8.11%
VTGN - CAI
23%
Poorly correlated
+11.52%
SNTI - CAI
21%
Poorly correlated
+13.15%
LIXT - CAI
20%
Poorly correlated
-2.32%
More

LIXT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIXT has been loosely correlated with PTHS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIXT jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
-2.32%
PTHS - LIXT
34%
Loosely correlated
-1.42%
IBIO - LIXT
28%
Poorly correlated
+12.56%
BBIO - LIXT
27%
Poorly correlated
+6.78%
CDXS - LIXT
26%
Poorly correlated
+4.72%
PMN - LIXT
26%
Poorly correlated
-2.82%
More